KR101364561B1 - 압축성형제제 - Google Patents

압축성형제제 Download PDF

Info

Publication number
KR101364561B1
KR101364561B1 KR1020060108839A KR20060108839A KR101364561B1 KR 101364561 B1 KR101364561 B1 KR 101364561B1 KR 1020060108839 A KR1020060108839 A KR 1020060108839A KR 20060108839 A KR20060108839 A KR 20060108839A KR 101364561 B1 KR101364561 B1 KR 101364561B1
Authority
KR
South Korea
Prior art keywords
mass
compression molding
cysteine
crystalline cellulose
ascorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020060108839A
Other languages
English (en)
Korean (ko)
Other versions
KR20070076388A (ko
Inventor
요이치 오누키
미노루 오카다
아키라 다카하시
미사오 무라타
데츠오 가네코
Original Assignee
에스에스 세야쿠 가부시키 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스에스 세야쿠 가부시키 가이샤 filed Critical 에스에스 세야쿠 가부시키 가이샤
Publication of KR20070076388A publication Critical patent/KR20070076388A/ko
Application granted granted Critical
Publication of KR101364561B1 publication Critical patent/KR101364561B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020060108839A 2006-01-16 2006-11-06 압축성형제제 Active KR101364561B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPJP-P-2006-00007331 2006-01-16
JP2006007331A JP5021210B2 (ja) 2006-01-16 2006-01-16 圧縮成型製剤

Publications (2)

Publication Number Publication Date
KR20070076388A KR20070076388A (ko) 2007-07-24
KR101364561B1 true KR101364561B1 (ko) 2014-02-18

Family

ID=38341887

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060108839A Active KR101364561B1 (ko) 2006-01-16 2006-11-06 압축성형제제

Country Status (4)

Country Link
JP (1) JP5021210B2 (https=)
KR (1) KR101364561B1 (https=)
CN (1) CN101002765B (https=)
TW (1) TWI414287B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8513261B2 (en) * 2009-03-13 2013-08-20 Toyama Chemical Co., Ltd. Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
JP5733930B2 (ja) * 2009-09-09 2015-06-10 武田薬品工業株式会社 固形製剤
BR112014027231A2 (pt) * 2013-01-15 2017-06-27 Fujifilm Corp comprimido contendo 5-hidróxi-1h-imidazola-4-carboxamida
JP6327237B2 (ja) * 2014-12-05 2018-05-23 大正製薬株式会社 固形組成物
JP7330716B2 (ja) * 2019-02-21 2023-08-22 アサヒグループ食品株式会社 アミノ酸又はその塩及びビタミンｃ含有組成物の変色抑制方法、並びに粉末組成物、顆粒、及び錠剤
JP6676816B1 (ja) * 2019-05-31 2020-04-08 シオノギヘルスケア株式会社 Ｌ−システイン配合ビタミンｃ高含有圧縮成形製剤
JP2023070979A (ja) * 2021-11-10 2023-05-22 トーアエイヨー株式会社 ベプリジルを含有する錠剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002179559A (ja) * 2000-10-06 2002-06-26 Takeda Chem Ind Ltd 薄層糖衣錠およびその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001322927A (ja) * 2000-05-12 2001-11-20 Shin Etsu Chem Co Ltd 低置換度ヒドロキシプロピルセルロース含有固形製剤及びその製造方法
JP2004026786A (ja) * 2002-05-10 2004-01-29 Takeda Chem Ind Ltd ビタミン製剤
CN1593411A (zh) * 2004-01-15 2005-03-16 范敏华 一种祛斑药物组合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002179559A (ja) * 2000-10-06 2002-06-26 Takeda Chem Ind Ltd 薄層糖衣錠およびその製造方法

Also Published As

Publication number Publication date
HK1104234A1 (en) 2008-01-11
CN101002765B (zh) 2011-10-12
CN101002765A (zh) 2007-07-25
JP5021210B2 (ja) 2012-09-05
TWI414287B (zh) 2013-11-11
TW200744572A (en) 2007-12-16
KR20070076388A (ko) 2007-07-24
JP2007186470A (ja) 2007-07-26

Similar Documents

Publication Publication Date Title
US20120171296A1 (en) Rapidly disintegrating solid preparation
JP5421945B2 (ja) イルベサルタンとアムロジピンまたはその塩を含有する医薬組成物
EP2815752B1 (en) Oral pharmaceutical composition
EP3395338A1 (en) Rapid dissolution formulation of cinacalcet hcl
EP4051246B1 (en) Bilayer tablet formulations comprising dapagliflozin and metformin
US20240374627A1 (en) A pharmaceutical composition comprising combination of sitagliptin and empagliflozin
US20090155369A1 (en) Pharmaceutical composition containing levodopa, entacapone and carbidopa
KR101364561B1 (ko) 압축성형제제
JP2022522005A (ja) Ｔｂｎ、又はその塩もしくは水和物を含む薬物組成物及びその製造方法
US20110274751A1 (en) Trimetazidine formulation with different release profiles
US20060222703A1 (en) Pharmaceutical composition and preparation method thereof
US12496293B2 (en) Solid pharmaceutical preparation
JP6328138B2 (ja) Ｎ−［５−［２−（３，５−ジメトキシフェニル）エチル］−２ｈ−ピラゾール−３−イル］−４−［（３ｒ，５ｓ）−３，５−ジメチルピペラジン−１−イル］ベンズアミドの医薬製剤
EP4008316A1 (en) A film coated tablet formulation comprising dapagliflozin and metformin hydrochloride
EP2468267B1 (en) Bilayer Combination Composition of Vildagliptin and Gliclazide
JP4393119B2 (ja) ヨウ化イソプロパミド含有製剤
JP5226732B2 (ja) 催眠用圧縮成型製剤
EP2233131A1 (en) Pharmaceutical composition containing levodopa, entacapone and carbidopa
BR112019028278A2 (pt) composições farmacêuticas
EP4556001A1 (en) A bilayer tablet composition comprising dapagliflozin and metformin
HK1104234B (en) Compression molded preparation
US20250195417A1 (en) Additive composition for orally disintegrating tablet
JP2004107258A (ja) 催眠用圧縮成型製剤
JP2019043964A (ja) 光安定性の向上した組成物
HK1152652B (en) Pharmaceutical solid preparation having active ingredients separated by boundary therein

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20170111

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

FPAY Annual fee payment

Payment date: 20180108

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 13